AGMB
AgomAb Therapeutics NV
8.60$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in EUR.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | 0.00 | |
| – | – | – | 0.00 | |
| 0.54 | 0.73 | 1.08 | 1.00 | |
| 0.12 | 0.17 | 0.27 | 0.26 | |
| 0.62 | 0.86 | 1.33 | 1.22 | |
| -0.62 | -0.86 | -1.33 | -1.22 | |
| 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.30 | -0.33 | -1.28 | -1.28 | |
| -0.07 | -0.02 | 0.00 | 0.00 | |
| -0.22 | -0.31 | -1.28 | -1.28 | |
| -0.30 | -0.33 | -1.27 | -1.28 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.